Hims & Hers Health, Inc. (HIMS) — Financial statements
Income statement, balance sheet, and cash flow for Hims & Hers Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,348↑59.0% | 1,477↑69.3% | 872↑65.5% | 527↑93.8% | 272 | |
| Cost of Revenue | 614↑102.5% | 303↑93.2% | 157↑32.9% | 118↑75.4% | 67 | |
| Gross Profit | 1,733↑47.8% | 1,173↑64.1% | 715↑74.9% | 409↑99.9% | 204 | |
| Operating Expenses | ||||||
| R&D Expenses | 149↑89.4% | 79↑63.4% | 48↑65.0% | 29↑30.6% | 22 | |
| General & Administrative Expenses | 273↑62.6% | 168↑29.2% | 130↑32.3% | 98↓13.6% | 114 | |
| Selling & Marketing Expenses | 919↑35.4% | 679↑52.1% | 446↑63.8% | 273↑100.6% | 136 | |
| SG&A Expenses | 1,192↑40.8% | 847↑46.9% | 576↑55.4% | 371↑48.6% | 250 | |
| Other Expenses | 286↑54.2% | 186↑55.0% | 120↑54.8% | 77↑62.6% | 48 | |
| Operating Expenses | 1,628↑46.5% | 1,111↑49.3% | 744↑55.9% | 477↑49.4% | 320 | |
| Total Costs & Expenses | 2,242↑58.5% | 1,415↑56.9% | 901↑51.3% | 596↑53.9% | 387 | |
| Operating Results | ||||||
| Operating Income | 106↑70.6% | 62↑310.2% | -29↑57.1% | -69↑40.3% | -115 | |
| Depreciation & Amortization | 55↑218.9% | 17↑79.6% | 10↑27.3% | 7↑83.4% | 4 | |
| EBITDA | 160↑102.7% | 79↑496.2% | -20↑67.4% | -61↑44.8% | -111 | |
| EBIT | 106↑70.6% | 62↑310.2% | -29↑57.1% | -69↑40.3% | -115 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 18↑86.7% | 10↑24.4% | 8↑163.8% | 3↓29.6% | 4 | |
| Income Before Tax | 124↑72.8% | 72↑432.4% | -22↑67.2% | -66↑40.7% | -111 | |
| Income Tax Expense | -4↑91.8% | -54↓2850.7% | 2↑6471.0% | -0.03↑99.0% | -3 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 128↑1.8% | 126↑635.3% | -24↑64.1% | -66↑39.0% | -108 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 128↑1.8% | 126↑635.3% | -24↑64.1% | -66↑39.0% | -108 | |
| Bottom-Line Net Income | 128↑1.8% | 126↑635.3% | -24↑64.1% | -66↑39.0% | -108 | |
| EPS (Basic) | 0.57↓1.7% | 0.58↑627.3% | -0.11↑65.6% | -0.32↑44.8% | -0.58 | |
| EPS (Diluted) | 0.51↓3.8% | 0.53↑581.8% | -0.11↑65.6% | -0.32↑44.8% | -0.58 | |
| Weighted Average Shares | 225↑4.2% | 216↑3.1% | 209↑2.4% | 205↑9.5% | 187 | |
| Weighted Average Diluted Shares | 258↑9.0% | 237↑13.1% | 209↑2.4% | 205↑9.5% | 187 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.